We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4188:TSEMitsubishi Chemical Group Corporation Analysis

Data as of 2026-06-21 - not real-time

¥1,092.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mitsubishi Chemical Group is trading at ¥1,092.5, comfortably above its 20‑day (¥1,089.9), 50‑day (¥1,016.3) and 200‑day (¥946.2) moving averages, indicating a short‑term bullish bias. The MACD line sits above its signal line and the histogram is positive, while the RSI hovers around 54, suggesting momentum is still intact but not overbought. Technical support sits near ¥999 and resistance near ¥1,163, giving the price a modest upside cushion despite a modest -2% upside/downside estimate from the DCF model. However, fundamentals are weak: trailing EPS is negative, operating margins are in the negative‑8% range, ROE is slightly below zero and debt‑to‑equity is high at roughly 78, raising concerns about financial resilience. Dividend yield looks attractive at 2.93% but the payout ratio exceeds 120%, implying the dividend may not be sustainable. Forward‑looking metrics are more encouraging – a forward PE of about 12 and a forward EPS of ¥91.18 – yet the DCF fair value of ¥156 is dramatically lower than the current price, flagging a substantial valuation gap. Volatility is elevated at roughly 48% over the past month, and while beta is modest, the basic‑materials sector faces medium regulatory scrutiny and cyclical demand pressures. Overall, the stock appears technically sound in the near term but fundamentally overvalued and financially strained.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup with price above key moving averages
  • Overvaluation indicated by DCF fair value far below market price
  • High dividend payout ratio questioning sustainability

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Improving forward earnings outlook but persistent negative margins
  • Elevated volatility and modest beta indicating price swings
  • Heavy debt load limiting financial flexibility

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental weakness: negative ROE, high leverage, and slim profit margins
  • Dividend likely to be cut given payout >100%
  • Valuation gap suggests price correction toward DCF estimate

Key Metrics & Analysis

Financial Health

Revenue Growth-10.10%
Profit Margin0.32%
P/E Ratio12.0
ROE-0.70%
ROA0.34%
Debt/Equity78.29
P/B Ratio0.8
Op. Cash Flow¥436.3B
Free Cash Flow¥112.5B

Technical Analysis

TrendBullish
RSI54.5
Support¥999.00
Resistance¥1,163.00
MA 20¥1,089.90
MA 50¥1,016.29
MA 200¥946.16
MACDBullish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value¥156.07
Target Price¥1,069.09
Upside/Downside-2.14%
GradeOvervalued
TypeValue
Dividend Yield2.93%

Risk Assessment

Beta0.47
Volatility48.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.